Ecologic® BARRIER
Reducing vulnerability to depression and improving brain function under stress
Medical need
Depression is a global burden, affecting the quality of life of millions of people worldwide. The gut-brain axis plays a crucial role in the communication between the gut and the brain. Specific probiotics could be a promising adjunctive therapy in the management of depressive symptoms.
Clinical outcomes of Ecologic® BARRIER
The premium probiotic formulation Ecologic® BARRIER has been tested in clinical trials. It has shown to:
• Significantly reduce overall cognitive reactivity to sad mood in adults.
• Significantly reduce cognitive reactivity in mild/moderate depressed adults.
• Significantly reduce depressive-like behaviour in rats.
• Significantly increase working memory performance in adults challenged with stress.
• Stable at room temperature: no refrigeration required.
• Excellent survival of the gastrointestinal tract.
• High viability and metabolic activity of bacteria.
